PATENT CLAIM ANALYSIS

Application Number: 15771136
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "229800"]

Abstract:
The present invention provides a compound of Formula (I) and stereoisomers thereof, and pharmaceutically acceptable salts of said compounds and said stereoisomers, and pharmaceutical compositions thereof, and methods for using said compounds and compositions for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Claim (Index 9):
The compound according to  claim 1 , or a pharmaceutically acceptable salt thereof, wherein:\n {circle around (A)} is or phenyl which is optionally substituted with one to three groups independently selected from the group consisting of halo, cyano, R 6 , OR 6 , C(O)OR 6 , C(O)OR 6 , NR 6 R 7 , NHC(O)O(C 1 -C 6 )alkyl, NHC(O)OC 3-6 cycloalkyl, \u2014NHSO 2 (C 1 -C 6 )alkyl, CONR 7 R 8 , and \u2014CH 2 CONR 7 R 8 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.64286
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15771538', '15305421', '15116659', '15329635', '15329609']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8213504259161449
- 35 USC 102 Novelty (BERT): 0.572305566576587
- Combined Prediction Score: 0.7964459399821892
- Mean Citation Score: 411.63498
- Max Citation Score: 453.12164
- Similarity Product: 401.5235333271789

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test